Can you detect prostate cancer or prostate enlargement?

Our screening may detect signs of prostate enlargement or prostate cancer, with some important nuances.

MRI (Advanced and Pro packages, or as a Core add-on via Gender health imaging): the prostate is included in the pelvic MRI and may reveal enlargement (benign prostatic hyperplasia, BPH), suspicious lesions, and structural abnormalities. Our screening uses a bi-parametric prostate MRI (bpMRI) protocol — in comparative studies, bpMRI has been shown to detect clinically significant prostate cancer with accuracy comparable to the more extensive multiparametric MRI (mpMRI), with the added benefit of no contrast agent. A dedicated mpMRI remains the standard for targeted diagnostic work-up when a suspicious finding needs further investigation.

PSA (prostate-specific antigen) is included in the Pro package and can also be added as a single-marker add-on on request. Elevated PSA can indicate BPH, inflammation, or cancer, but PSA alone cannot distinguish between these conditions.

If our screening raises any concerns, our physicians will guide you through the appropriate next steps, which may include a referral to a urologist for further evaluation.

See our conditions overview for more on what our screening may detect.